CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.15
arrow_downward
-1.24%(-0.090) 1D
Nov 20, 4:10:07 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.18
High
A$7.22
Low
A$7.07
Mkt. cap
360.98M
Avg. vol.
158.22K
Volume
97.17K
Dividend
0.70%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
10.70
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.18
High
A$7.22
Low
A$7.07
Mkt. cap
360.98M
Avg. vol.
158.22K
Volume
97.17K
Dividend
0.70%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
10.70
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
24/7 Wall St.
·
14 minutes ago
His Indexed Annuity Tracks the S&P 500. The Fine Print Says "Price Return," Which Means It Leaves Out Every Dividend the 500 Companies Pay
Nacionale
·
1 hour ago
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Benzinga
·
16 minutes ago
S&P 500 Has Slumped Into a Correction as Goldman Sachs Panic Index Points to More Downside
cwibc.co.id
·
2 hours ago
S&P 500 Tech Sector Falls 23% Into Bear Market
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com